Friday, August 24, 2018 10:14:25 AM
I'm a LONG investor on CELZ and I’m not going anywhere. I have not sold a single share even in the drop from 7 cent to here. CELZ is ROCK SOLID. Are there less than warm n fuzzies with the reality of funding a startup doing peer reviewed research and filing 13 PATENTS? Sure there are. Do we all wish they could of/would of crowd-sourced their cash needs from us faithful who had it to lend instead of obtaining funding from the loan sharks? Of course. BUT, in spite of the traditional ways of financing OTC startup operations, CELZ is doing something remarkable. They obtained 13 loans through June 30, 2018. They have already paid or converted ~ 8 of 13 and the last loan was a traditional non-convertible business loan at a respectable 8% interest rate (June 27th loan.) - They also PAID OFF ALL 2017 LOANS totaling $620,000 by June 30th. And then there's that whole other thing called SIGNING UP DOCTORS UNDER LICENSE and then signing a national Russian Contract, and then, oh yeah, Caverstem-Switzerland.com anybody? That's right...only the finest minds and conservative people on the planet and their top urologist has signed up to be THE agent for training all European docs signing up to be Caverstem providers.
Please understand that all posts related to OS increases by CMTH being TOXIC and AWFUL for the stock just simply aren't true. IF CELZ wasn't creating amazing value and actually generating revenues then it would be pretty bad. BUT, CELZy's value is growing in spades! IT IS! And the 10Q shows proof of concept turning into proof of revenue. The 10Q actually says so on page 35 of 39 if printed from SEC website: ..."The decrease in cash used in operations was primarily related to a $48,466 increase in accounts payable, a $20,000 pre-payment from a new Caverstem customer, and $38,300 lower payments towards an outstanding balance of management fees payable to a related party." Caverstem matters more than making a phone call or snapping a picture and I guarantee at least half of the world's population would agree with that statement.
So, back to the subject line regarding OS not being scary...
CELZ's Outstanding Shares in Dec '17: 106,323,582 PPS was $0.0135
CELZ's Outstanding Shares on Mar '18: 188,131,817 PPS avg $0.0025
CELZ's Outstanding Shares on Jun '18: 623,924,281 PPS avg $0.035
DECEMBER TO JUNE THE PPS WENT UP 1,592%. The OS INCREASED by 517M shares or 487% Ask yourself this question: Does it matter if the number of shares increase by a trillion shares if YOUR (now diluted) shares actually go up in 1,592% in value per share? The answer is not one bit. What does all those new owners in the company do? They create much higher LIQUIDITY which will help STABILIZE PPS. Increasing OS can be really quite good if you can get past the nitty gritty and the scary fear inducing misrepresentation.
If the 93 Million in potential dilution were still fully in play (per fact found in Note 5 of the 10Q) and were to convert this month, they would have an OS at ~ 810M shares. IF the share price were to increase on that increase like it did in Q2 of 2018 (1,580% INCREASE in PPS with 435M OS increase) than the next soon to be PPS could easily be ~ $0.40 cents or more. Is this scenario more likely than a "toxic bankruptcy"? Think for yourself. They signed and publicly announced 7 new doctors signed up after the AUA conference and they have 50 domain names secured ALREADY. That doesn't include Russia or Europe. And many of us LONGS believe that International is worth MORE than Domestic. So, for me personally, I think CELZ is easily worth 50 cents PPS on it's (IP) intellectual property alone. Factor in Revenue from all that crazy licensing and kit selling activity and the PPS is EASILY OVER A DOLLAR.
If you are patient long enough...you can water in a sieve. You just have to wait for it to freeze. Wait folks, CELZ is going to be worth the carry.
AIMHO. GOOD LUCK TO TRUE LONGS!
Recent CELZ News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 08:45:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:10:25 PM
- Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program • GlobeNewswire Inc. • 07/24/2024 01:00:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • GlobeNewswire Inc. • 07/10/2024 12:30:00 PM
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM